Neogen Corporation's stock fell as much as 7.22% following an FDA warning about its recalled equine product HYCOAT, which was found to contain multiple fungal species. The contamination reportedly affected nearly 100 horses and caused at least 20 deaths. An investigation is underway to determine if Neogen misled investors about product quality before the warning became public. Investors who suffered losses may be eligible to seek compensation, with legal firms encouraging affected shareholders to submit their trading records for review. Neogen's next earnings report is due on October 6, 2026.
Neogen Investigation Notice provides context for readers interested in health-sector stocks. For readers following this sector, here is Pluang's market snapshot as of Oct 01, 2026 01:11 WIB: Among 100 priced health-sector US stocks, 48 rose and 52 fell. Notably, HRTX gained 5.58% with a typical hold time of 35 days and a Pluang order activity skewed 74% Sell / 26% Buy, contrasting with MRNA which dropped 5.52% and had a longer typical hold time of 59 days and 79% Sell / 21% Buy. Meanwhile, HIMS rose 5.47% with a very short typical hold time of 20 days and a strong buy interest at 99%.
XRP trades around $1.51, holding steady near the $1.50 mark since late September. A key event is the shareholder vote in New York on the merger creating Evernorth, a company holding 473 million XRP, which would list on Nasdaq under ticker XRPN. This ...
The Panamanian Ministerial Commission has recommended opening formal negotiations with First Quantum Minerals and Cobre Panamá to end ongoing international arbitrations and explore a new agreement for the mine's orderly restart. The proposal prioriti...
DogeOS has launched the Chikyū public testnet, an EVM-compatible Layer 2 built on ZK-rollup technology for Dogecoin. This new layer boosts transaction speed to around 300 TPS and enables smart contracts, DeFi, and gaming using DOGE as the native gas ...
Cardano's price dropped 3.19% last week but stabilized near $0.246, with buyers defending the $0.24 support level. While some speculate ADA could reach $2, this would require a 700% gain and faces challenges due to weak DeFi activity and declining to...
A class action lawsuit has been filed against Fluence Energy, alleging the company made false statements about its ability to fulfill backlog and meet revenue guidance due to incomplete and non-operational manufacturing facilities. The lawsuit claims...
